Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
INCHEON, South Korea, Sept 21 (Bernama-BUSINESS WIRE) — Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS)…